In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.

In vitro activity of LB20304 against 1,231 clinical isolates was evaluated and compared with those of ciprofloxacin, sparfloxacin, lomefloxacin, and ofloxacin. LB20304 demonstrated the most potent activity against gram-positive bacteria. It was 32- to 64-fold more active than ciprofloxacin against m...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Oh, J I, Paek, K S, Ahn, M J, Kim, M Y, Hong, C Y, Kim, I C, Kwak, J H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8726042/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.6.1564
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!